董事相信，可能收购事项一旦落实，可为集团现有业务带来协同效益。透过整合目标公司和集团的资源、渠道及市场优势，集团将进一步发展医疗器械及耗材贸易业务，增强在该领域的竞争力和市场地位。Zyy (08223) announced that on September 27, 2024, the company (buyer) entered into a Memorandum of Understanding with Shenzhen Hongyang Xintian Industrial Development Partnership Enterprise (Limited Partnership), Shenzhen Hongyang Xintian Management Partnership Enterprise (Limited Partnership), and Foshan Shuoduoduo Trading Co., Ltd. (seller).
Wisdom Financial News App reported that Zyy (08223) announced that on September 27, 2024, the company (buyer) intends to purchase shares of Hongyang Xintian (Shenzhen) Technology Co., Ltd. (target company) that the seller intends to sell.
The target company is a limited company established in China in 2023, dedicated to the research and development, production, and operation of port biosecurity control and treatment technology. It has successfully developed a new generation of quarantine treatment technology 'Fully Automatic Vacuum Steaming Quarantine Treatment Technology' with seven patented technologies.
Directors believe that once the possible acquisition is finalized, it can bring synergies to the group's existing operations. By integrating the resources, channels, and market advantages of the target company and the group, the group will further develop the medical instruments and consumables trading business, enhancing its competitiveness and market position in this field.
